First-Line Treatment of IDA in NDD-CKD
This promotional article was developed in conjunction with and sponsored by Daiichi Sankyo, Inc.
May 14, 2020|Internal Medicine
In this supplement to Internal Medicine News, Kamyar Kalantar-Zadeh, MD, MPH, PhD, discusses a first-line treatment option for iron deficiency anemia (IDA) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Topics include:
- The interplay between IDA and CKD
- Recognizing IDA in patients with CKD
- First-line treatment efficacy and safety information